Indeed, CYLD is located in chromosome 16q and its expression is reduced in 16q-loss cancer groups (A, B1, and D), thus suggesting that its decreased function could cooperate in the hyperactivation of conventional or non-conventional Wnt pathways. Here, CYLD is linked to cancer.